Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg Versus 1.0 mg in Patients With Type 2 Diabetes (SUSTAIN FORTE): A Double-Blind, Randomised, Phase 3B Trial
This context helps you discuss options with your healthcare team
Embrace a Healthier Future In addition to weight loss, semaglutide and tirzepatide have also been found to have other health benefits, including a reduction in the overall risk of cardiovascular and stroke morbidity
The formulations may vary slightly, but the goal is usually the same: metabolic and energy support
As the mitochondria fail, the patient experiences a catastrophic drop in available cellular energy, making even minor physical or cognitive tasks feel impossible
10.1016/j.physbeh.2016.10.006 48 SirohiS.Van CleefA.DavisJ